Kingdon Capital Management Llc acquired 390,092 shares as Antares Pharma Inc (ATRS)’s stock 0.00%. The Kingdon …
It's important to get a feel for how any stock is actually valued on the market based on its core numbers. In recent trading day AntaresPharma, Inc. Antares Pharma (NASDAQ:ATRS) last announced its earnings results on Tuesday, May 9th. …
Antares Pharma Inc. (NASDAQ:ATRS) was a big mover last session ... led to solid volume too with far more shares changing hands than in a normal session. This stock, trading in a volatile price range of $0.95–$1.17 in the past one …
Antares Pharma, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. It has one operating segment, drug delivery, which …
Today, Piper Jaffray Companies reiterated its Buy rating on Antares Pharma (NASDAQ:ATRS) with a price target of $4.00. There are 3 buy ratings, 1 strong buy rating on the stock. The current consensus rating on Antares Pharma …
The Vetr community has upgraded Antares Pharma Inc. (NASDAQ: ATRS) from 4 stars to 5 stars. The stock has traded up a little under $1 year-to-date with its second-quarter earnings report coming up on August 8. Vetr members have …
Is Antares Pharma Inc (NASDAQ:ATRS) undervalued? The best stock pickers are getting more bullish. The number of …
A year ago, they were trading at $1.10. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRS at https://www.zacks.com/ap/ATRS
CNBC13d
If you want a Stock Review on ATRS, IART, BDX, or WAT then come over to http://dailystocktracker.com/register/ and …
Antares Pharma Inc. was a big mover last session, as the company saw its shares rise more than 10% on the day. Shares moved up after the company along with Teva Pharmaceutical Industries Ltd announced the launch of the generic …